With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

The North Texas hospital system joins over 400 other entities and a dozen state attorneys general suing over alleged ...

Insulin device maker Insulet Corporation (NASDAQ ... The analyst maintains the Outperform rating. Price Action: PODD stock is down 7.35% at $185.11 at last check on Friday.

Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...

Insulet has persuaded a jury that rival South Korean company EOFlow stole trade secrets relating to its wearable insulin pump technology, awarding it a whopping $452 million in damages.